Literature DB >> 28239144

Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.

K Hussein1, A Stucki-Koch1, G Göhring2, H Kreipe1, M Suttorp3.   

Abstract

Paediatric chronic myeloid leukaemia (ped-CML) is rare and ped-CML with fibre accumulation in the bone marrow (MF) is thought to be even rarer. In adults (ad-CML), fibrosis represents an adverse prognostic factor. So far, the pro-fibrotic changes in the bone marrow microenvironment have not been investigated in detail in ped-CML. From a total of 66 ped-CML in chronic phase, biopsies were analysable and 10 had MF1/2 (MF1, n=8/10; MF2, n=2/10). We randomly selected 16 ped-CML and 16 ad-CML cases with and without fibrosis (each n=8) as well as 18 non-neoplastic controls. Bone marrow samples were analysed with a real-time PCR-based assay (including 127 genes for paediatric cases) and by immunohistochemistry. We found increased expression of megakaryocytic genes in ped-CML. The number of megakaryocytes and pro-platelets are increased in CML patients, but the most significant increase was noted for ped-CML-MF1/2. Anti-fibrotic MMP9 expression was lower in children than in adults. Cell mobilisation-related CXCL12 was decreased in young and adult patients with CML but not the corresponding receptor CXCR4. In summary, fibre accumulation in ped-CML-MF1/2 is associated with increased megakaryocytic proliferation and increased interstitial pro-platelet deposition. Deregulated expression of matrix-modulating factors shifts the bone marrow microenvironment towards fibrosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28239144     DOI: 10.1038/leu.2017.73

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  54 in total

1.  Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.

Authors:  G Buesche; M Freund; R Hehlmann; A Georgii; A Ganser; H Hecker; H Heimpel; C Fonatsch; B Heinze; M Pfirrmann; S Holgado; A Schmeil; A Tobler; J Hasford; T Buhr; H-H Kreipe
Journal:  Leukemia       Date:  2004-09       Impact factor: 11.528

2.  Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status.

Authors:  Oliver Bock; Johanne Neuse; Kais Hussein; Kai Brakensiek; Guntram Buesche; Thomas Buhr; Birgitt Wiese; Hans Kreipe
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.

Authors:  Alice Fabarius; Lida Kalmanti; Christian T Dietz; Michael Lauseker; Sébastien Rinaldetti; Claudia Haferlach; Gudrun Göhring; Brigitte Schlegelberger; Martine Jotterand; Benjamin Hanfstein; Wolfgang Seifarth; Mathias Hänel; Claus-Henning Köhne; Hans W Lindemann; Wolfgang E Berdel; Peter Staib; Martin C Müller; Ulrike Proetel; Leopold Balleisen; Maria-Elisabeth Goebeler; Jolanta Dengler; Christiane Falge; Lothar Kanz; Andreas Burchert; Michael Kneba; Frank Stegelmann; Michael Pfreundschuh; Cornelius F Waller; Karsten Spiekermann; Tim H Brümmendorf; Matthias Edinger; Wolf-Karsten Hofmann; Markus Pfirrmann; Joerg Hasford; Stefan Krause; Andreas Hochhaus; Susanne Saußele; Rüdiger Hehlmann
Journal:  Ann Hematol       Date:  2015-09-18       Impact factor: 3.673

4.  Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.

Authors:  Xabier Agirre; Antonio Jiménez-Velasco; Edurne San José-Enériz; Leire Garate; Eva Bandrés; Lucia Cordeu; Oscar Aparicio; Borja Saez; Germán Navarro; Amaia Vilas-Zornoza; Ignacio Pérez-Roger; Jesús García-Foncillas; Antonio Torres; Anabel Heiniger; María José Calasanz; Puri Fortes; José Román-Gómez; Felipe Prósper
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

5.  Myeloproliferative Neoplasms in Children.

Authors:  Inga Hofmann
Journal:  J Hematop       Date:  2015-08-02       Impact factor: 0.196

6.  Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.

Authors:  Eda Tanrikulu Simsek; Ahmet Emre Eskazan; Mahir Cengiz; Muhlis Cem Ar; Seda Ekizoglu; Ayse Salihoglu; Emine Gulturk; Tugrul Elverdi; Seniz Ongoren Aydin; Ahu Senem Demiroz; Ayse Nur Buyru; Zafer Baslar; Ugur Ozbek; Burhan Ferhanoglu; Yildiz Aydin; Nukhet Tuzuner; Teoman Soysal
Journal:  J Clin Pathol       Date:  2016-01-25       Impact factor: 3.411

7.  Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia.

Authors:  Bin Zhang; Yin Wei Ho; Qin Huang; Takahiro Maeda; Allen Lin; Sung-Uk Lee; Alan Hair; Tessa L Holyoake; Claudia Huettner; Ravi Bhatia
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

8.  Hypoxia Induces Mesenchymal Gene Expression in Renal Tubular Epithelial Cells: An in vitro Model of Kidney Transplant Fibrosis.

Authors:  Stephanie Zell; Roland Schmitt; Sandra Witting; Hans H Kreipe; Kais Hussein; Jan U Becker
Journal:  Nephron Extra       Date:  2013-06-06

9.  Differential regulation of myeloid leukemias by the bone marrow microenvironment.

Authors:  Daniela S Krause; Keertik Fulzele; André Catic; Chia Chi Sun; David Dombkowski; Michael P Hurley; Sanon Lezeau; Eyal Attar; Joy Y Wu; Herbert Y Lin; Paola Divieti-Pajevic; Robert P Hasserjian; Ernestina Schipani; Richard A Van Etten; David T Scadden
Journal:  Nat Med       Date:  2013-10-27       Impact factor: 53.440

10.  Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.

Authors:  Lida Kalmanti; Susanne Saussele; Michael Lauseker; Ulrike Proetel; Martin C Müller; Benjamin Hanfstein; Annette Schreiber; Alice Fabarius; Markus Pfirrmann; Susanne Schnittger; Jolanta Dengler; Christiane Falge; Lothar Kanz; Andreas Neubauer; Frank Stegelmann; Michael Pfreundschuh; Cornelius F Waller; Karsten Spiekermann; Stefan W Krause; Dominik Heim; Christoph Nerl; Dieter K Hossfeld; Hans-Jochem Kolb; Andreas Hochhaus; Joerg Hasford; Rüdiger Hehlmann
Journal:  Ann Hematol       Date:  2013-10-27       Impact factor: 3.673

View more
  3 in total

1.  Expansion of senescent megakaryocyte-lineage cells maintains CML cell leukemogenesis.

Authors:  Yamato Tanabe; Shimpei Kawamoto; Tomoiku Takaku; Soji Morishita; Atsushi Hirao; Norio Komatsu; Eiji Hara; Naofumi Mukaida; Tomohisa Baba
Journal:  Blood Adv       Date:  2020-12-22

Review 2.  Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia.

Authors:  Naofumi Mukaida; Yamato Tanabe; Tomohisa Baba
Journal:  Mol Biomed       Date:  2021-03-10

Review 3.  MiRNA Dysregulation in Childhood Hematological Cancer.

Authors:  Jaqueline Carvalho de Oliveira; Gabriela Molinari Roberto; Mirella Baroni; Karina Bezerra Salomão; Julia Alejandra Pezuk; María Sol Brassesco
Journal:  Int J Mol Sci       Date:  2018-09-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.